Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
about
Modulation of Autophagy by Sorafenib: Effects on Treatment ResponseTranslating discovery in zebrafish pancreatic development to human pancreatic cancer: biomarkers, targets, pathogenesis, and therapeuticsHistone deacetylase inhibitors interact with melanoma differentiation associated-7/interleukin-24 to kill primary human glioblastoma cells.The rationale for targeted therapies in medulloblastoma.The multi-hit hypothesis in basal-like breast cancer.HDAC inhibitors enhance the lethality of low dose salinomycin in parental and stem-like GBM cellsThe HDAC inhibitor AR42 interacts with pazopanib to kill trametinib/dabrafenib-resistant melanoma cells in vitro and in vivo.The role of chromatin remodeling in medulloblastoma.Molecular pathways and potential therapeutic targets in glioblastoma multiforme.Silencing of histone deacetylase 2 suppresses malignancy for proliferation, migration, and invasion of glioblastoma cells and enhances temozolomide sensitivity.HDAC inhibitors enhance the immunotherapy response of melanoma cells.Epigenetic regulation in medulloblastoma.The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells.
P2860
Q26745320-E7AFB3FA-D53D-40F8-8AFA-C6F6B67F53E0Q28468696-433BE92C-8041-493F-8A15-F1810D376108Q37027060-89839E48-67CB-4BB3-AD4F-014841AEEA77Q37409736-4A349B92-BEEC-455A-BB08-A6584E7A1F9BQ37540182-CE527501-9297-4932-9721-340FFFD2DA9DQ37683049-69474797-C250-4BBD-839C-B24AE8BAEF16Q37725434-81F5CA55-0BC0-4606-A3CC-8D8504A36EF0Q38083796-BAED3AAA-987F-4603-9FE1-94A1CEAE45D6Q38156191-857F8D73-9920-42A8-ABAB-A845A47694E3Q38731925-8914B20A-9ED6-4EAD-8BBA-B1A0CD1538BEQ45072959-9E52F49D-D357-445C-A6AF-E708D4441230Q47900778-E248CE44-630B-46AB-A650-0B5198EB704AQ48117089-A787E736-381A-431D-8760-8BD3BF937BDC
P2860
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@en
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@nl
type
label
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@en
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@nl
prefLabel
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@en
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@nl
P2093
P2860
P356
P1476
Sorafenib and HDAC inhibitors synergize to kill CNS tumor cells.
@en
P2093
Adly Yacoub
Andrew Poklepovic
Hossein A Hamed
Steven Grant
P2860
P304
P356
10.4161/CBT.19771
P50
P577
2012-05-01T00:00:00Z